South Florida Research Phase I-IV — Miami, Florida

South Florida Research Phase I-IV is a clinical research site located in Miami, Florida, United States 33166.

Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.

South Florida Research Phase I-IV has participated in 12 clinical trials with 10 currently active.

Therapeutic areas: Irritability Associated With Autism Spectrum Disorder, Alzheimer Disease, Bipolar-I Disorder With Mania or Mania With Mixed Features.

Sponsors: Intra-Cellular Therapies, Inc., Eli Lilly and Company, Bristol-Myers Squibb.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Miami

Browse all research sites in Florida · View every site in Miami

Sponsor Feasibility Report

Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for South Florida Research Phase I-IV?

South Florida Research Phase I-IV has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has South Florida Research Phase I-IV conducted?

South Florida Research Phase I-IV has 12 clinical trials on record, with 10 currently active. Their work covers Irritability Associated With Autism Spectrum Disorder, Alzheimer Disease, Bipolar-I Disorder With Mania or Mania With Mixed Features.

Is South Florida Research Phase I-IV accredited by Crixeo Clinical Trials?

South Florida Research Phase I-IV has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about South Florida Research Phase I-IV?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.